Watching
MAN · ManpowerGroup
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 9 October 2026; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A weekly close below $52, which would give back the gap the shares opened after the 16 July 2026 second-quarter report; third-quarter GAAP EPS below the $0.96 low end of guidance on 15 October 2026 would break the business case.
Not a pickResearch coverage at low conviction. A medium-or-higher call would open a pick on the scoreboard.
Catalyst (in 3 days)
How picks are graded →The thesis
ManpowerGroup's staffing recovery is priced ahead of its proof, and the 15 October 2026 third-quarter report settles it. The company guided to GAAP diluted earnings per share (EPS) of $0.96–$1.06 against an $0.88 consensus, and the shares need that guide met to regain momentum. The close on 30 September 2026 was $55.58, 11.7% below the 52-week high of $62.95 and still 43.3% higher over three months.
The case rests on one strong quarter. The company's 16 July 2026 release reported second-quarter revenue of $4.860 billion against a $4.723 billion estimate and adjusted EPS of $0.99. The company's 8 September 2026 hiring survey put the fourth-quarter global Net Employment Outlook at 29%, which measures employer intentions rather than orders.
The narrative is maturing: the recovery story is well known, no analyst target change has been located since the July 2026 cluster, and the shares have slipped from their high while waiting for the next report. The company's investor events page lists the third-quarter call for 15 October 2026 at 8:30 a.m. Eastern, read on 1 October 2026. The shares now trade mainly on that one dated report.
Bullish and bearish views on ManpowerGroup
The bull case on ManpowerGroup (MAN), in brief: Guidance sits above the Street. The bear case: Price already sits near consensus targets.
Bull case
- Guidance sits above the Street. On 16 July 2026 management guided third-quarter GAAP diluted EPS to $0.96–$1.06 versus an $0.88 consensus, including about 2 cents of currency headwind. A result inside that range would give two consecutive quarters of improvement.
- Second quarter beat on every line. GAAP EPS was $1.13 against a $0.83 estimate and adjusted EPS $0.99 against $0.95, per the 16 July 2026 release. Revenue grew 6% excluding currency movements.
- Employer hiring intentions firmed. The 8 September 2026 survey of 39,878 employers in 42 countries put the global fourth-quarter outlook at 29%. Responses were collected in July 2026.
Bear case
- Price already sits near consensus targets. The consensus target is $57.33 (stockanalysis.com and Investing.com, read 1 October 2026), with a range from Barclays' $47 to Baird's $72, all set in July 2026. Most firms rate the shares Hold or Neutral, including Goldman Sachs at $57, UBS at $55 and Truist at $50.
- Headline profit included one-off gains. The second-quarter GAAP EPS of $1.13 included a net $0.14 per-share benefit from disposals and other items, per the 16 July 2026 release. The third-quarter guide is also GAAP and assumes a 44% effective tax rate, so tax or currency swings can move the reported figure.
- Momentum has faded since mid-September. The 14-day relative strength index (RSI) read 41.4 on 30 September 2026. Alphastreet reported a 5.6% one-day drop on 8 September 2026 amid sector-wide selling in staffing stocks.
- Europe lags the global reading. Europe, the Middle East and Africa recorded a 22% outlook in the 8 September 2026 survey, below the 29% global figure. Europe is the company's largest source of revenue.
Price setup
The shares closed at $55.58 on 30 September 2026, 11.7% under the $62.95 52-week high. The three-month gain of 43.3% on that date compares with 84.0% on 18 September 2026, as the July post-earnings jump moves out of the measurement window. An RSI of 41.4 sits in neutral territory, neither stretched nor oversold.
The $52 level marks the gap the shares opened after the 16 July 2026 report. A weekly close below it would return the price to where it traded before that report.
Crowding evidence is dated. StockTitan displayed short interest of 6.3 million shares, 13.7% of float and 5.3 days to cover, on 16 August 2026, the latest reading located. The largest observable concentration of risk is the earnings date inside the next 30 days.
Catalysts, next 30 days
- 15 October 2026 — Third-quarter 2026 results, call at 8:30 a.m. Eastern. Settles whether GAAP EPS lands inside the $0.96–$1.06 guide and what management guides for the fourth quarter.
- ~23 October 2026 (est.) — Flash eurozone composite PMI (purchasing managers' index) for October. The employment component is the most frequent proxy for hiring in the company's largest region.
Elapsed catalysts
- ~2 October 2026 (est.) — US Employment Situation for September (BLS). The first revision to the 162,000 August gain and the next direct read on US labour demand. (passed 10d ago)
What would change the view
The case breaks if third-quarter GAAP EPS prints below the $0.96 low end of guidance on 15 October 2026, or if the fourth-quarter guide lands below consensus. Constant-currency revenue growth slowing from the second quarter's 6% would show the recovery stalling. A downward revision to August payrolls at the ~2 October 2026 BLS release would weaken the macro support.
On price, a weekly close below $52 would give back the July post-earnings gap. The read would strengthen if the report clears the guide, firms lift targets above the $57.33 consensus, and the shares close above the $62.95 high.
What it trades with
The shares move with staffing peers; the 8 September 2026 drop came during selling across the group, per Alphastreet. US payroll releases and rate expectations drive the sector together. Europe's weight ties reported results to the euro, so currency translation can move earnings regardless of hiring volumes.
Notes
- The dividend is semi-annual, not quarterly: $0.72 was declared 8 May 2026 and paid 15 June 2026.
- Quarterly guidance is GAAP diluted EPS including currency effects and an assumed tax rate, so reported EPS can diverge from operating results in either direction.
- Europe is the company's largest revenue source, so reported results carry euro translation risk independent of hiring volumes.
- Double-digit short interest as a share of float has amplified single-session moves in both directions.
Related · shared themes
LFST
LifeStance Health Group, Inc.
LifeStance Health's third-quarter profit guidance of $49–59 million sits below its $66.0 million second-quarter result, while the shares trade under September's $12.35 offering price; the report expected around 5 November 2026 shows whether the guidance holds or rises.
MTW
The Manitowoc Company, Inc.
Manitowoc's crane-order recovery still supports the shares after a pullback to $21.72; the third-quarter report, expected about 5 November 2026, shows whether backlog holds $1,050.1 million and the $150–170 million EBITDA guidance survives.
RCMT
RCM Technologies, Inc.
RCM Technologies' shares sit at a 52-week high because energy-services work made Engineering its growth engine; the Q3 report, estimated for early-to-mid November 2026, must show Engineering revenue above $39.5 million and gross margin of at least 25.7% to confirm it.
STLN
Starling Oncology, Inc.
Starling Oncology's shift to capitated oncology contracts is lifting gross profit faster than revenue; the third-quarter 2026 report, estimated for 12 November, settles whether adjusted EBITDA lands in the guided $500,000–$1.5 million range with full-year guidance intact.